{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:41:48Z","timestamp":1787013708293,"version":"build-2736575974"},"reference-count":33,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T00:00:00Z","timestamp":1658275200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Emerg Medicine Australasia"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The aim of the present study was to obtain an unbiased understanding of the prevalence of psychoactive drugs in trauma patients presenting to a large ED.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Consecutive adult patients presenting to the ED with an injury resulting in a trauma call had an anonymised, additional blood test taken for detection of over 2000 drugs. Laboratory testing was to judicial standards. Drugs given by ambulance pre\u2010hospital were detected but excluded from the analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Over 6\u2009months 276 (74.7%) of 371 patients were tested. Of the 276 patients tested, 158 (57.2%) had one or more psychoactive drug present. Recreational drugs were detected in 101 (36.6%) patients and medicinal drugs in 88 (31.8%) patients, with a combination of both detected in 31 (11.2%) patients. The most common drugs detected were cannabis (22.1%), antidepressants (18.4%), alcohol (15.5%), opioids (10.1%), benzodiazepine\/z\u2010drugs (9.4%) and methamphetamine (7.2%). The prevalence of psychoactive drugs differed by age group, sex and cause of injury.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The prevalence of psychoactive drugs in injury presentations to an ED is high, and provides an opportunity to reduce harm. The present study demonstrates the feasibility of an approach which limits bias and obtains results that accurately reflect the drug prevalence in injured cohorts. Systematic testing of injured patients is an important contribution to the epidemiology of injury.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/1742-6723.14040","type":"journal-article","created":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T21:28:03Z","timestamp":1658352483000},"page":"25-33","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Prevalence of psychoactive drugs in injured patients presenting to an emergency department"],"prefix":"10.1111","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2926-8468","authenticated-orcid":false,"given":"Siobhan","family":"Isles","sequence":"first","affiliation":[{"name":"National Trauma Network  Wellington New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2348-3207","authenticated-orcid":false,"given":"Paul","family":"McBride","sequence":"additional","affiliation":[{"name":"Health Quality and Safety Commission  Wellington New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1515-761X","authenticated-orcid":false,"given":"Paul","family":"Gee","sequence":"additional","affiliation":[{"name":"Emergency Department Christchurch Hospital  Christchurch New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"Fleischer","sequence":"additional","affiliation":[{"name":"Emergency Department Christchurch Hospital  Christchurch New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1599-4602","authenticated-orcid":false,"given":"Diana","family":"Kappatos","sequence":"additional","affiliation":[{"name":"Institute of Environmental Science and Research  Porirua New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0083-9466","authenticated-orcid":false,"given":"Rishi","family":"Pandey","sequence":"additional","affiliation":[{"name":"Institute of Environmental Science and Research  Porirua New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1371-1114","authenticated-orcid":false,"given":"Ian","family":"Civil","sequence":"additional","affiliation":[{"name":"National Trauma Network  Wellington New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7096-7688","authenticated-orcid":false,"given":"Belinda","family":"Gabbe","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine Monash University  Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,7,20]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1080\/09595230601146686"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-74753-y"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-13-1076"},{"key":"e_1_2_9_5_1","unstructured":"New Zealand Transport Agency.Risks of Driving When Affected by Cannabis MDMA (Ecstasy) and Methamphetamine and the Deterrence of Such Behaviour: A Literature Review.2020. [Cited 4 Nov 2021.] Available from URL:https:\/\/www.nzta.govt.nz\/resources\/research\/reports\/664"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sbspro.2012.06.1259"},{"key":"e_1_2_9_7_1","volume-title":"The Prevalence and Relative Risk of Drink and Drug Driving in the Netherlands: A Case\u2010Control Study in the Tilburg Police District","author":"Mathijssen R","year":"2005"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2012.01919.x"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1080\/10826084.2021.1892139"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2005.08.017"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/aas.13807"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.aap.2008.06.015"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1080\/15389588.2018.1478087"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.aap.2008.10.002"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.aap.2020.105905"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1080\/17457300.2012.748809"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.aap.2014.02.019"},{"key":"e_1_2_9_18_1","unstructured":"New Zealand Police.National Wastewater Testing Programme Results Quarter 1 2020. [Cited 17 Nov 2021.] Available from URL:https:\/\/www.police.govt.nz\/about-us\/publication\/national-wastewater-testing-programme-quarter-1-2020"},{"key":"e_1_2_9_19_1","unstructured":"Immunalysis.IMMUNALYSIS Cannabinoids (THCA\/CTHC) Direct ELISA Kit 205\u20100192. [Cited 17 Nov 2021.] Available from URL:https:\/\/immunalysis.com\/products\/elisa\/elisa-for-forensic\/"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2014.07.026"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2016.07.009"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/dta.2030"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/dta.2697"},{"key":"e_1_2_9_24_1","unstructured":"Heath and Disability Commissioner.Code of Health and Disability Services Consumers Rights.1996. Available from URL:https:\/\/www.hdc.org.nz\/your-rights\/about-the-code\/code-of-health-and-disability-services-consumers-rights\/"},{"key":"e_1_2_9_25_1","unstructured":"ThomasFD BerningA DarrahJet al.Drug and Alcohol Prevalence in Seriously and Fatally Injured Road Users before and during the COVID\u201019 Public Health Emergency.2020. [Cited 4 Nov 2021.] Available from URL:https:\/\/rosap.ntl.bts.gov\/view\/dot\/50941"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12873-016-0085-2"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1080\/15389588.2012.716881"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-009278"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2014.01.019"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-032572"},{"key":"e_1_2_9_31_1","unstructured":"Centers for Disease Control and Prevention.Annual Surveillance Report of Drug\u2010Related Risks and Outcomes \u2013 United States. Surveillance Special Report.2018. [Cited 4 Nov 2021.] Available from URL:https:\/\/www.cdc.gov\/drugoverdose\/pdf\/pubs\/2019\u2010cdc\u2010drug\u2010surveillance\u2010report.pdf"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40621-017-0107-x"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2012.01.001"},{"key":"e_1_2_9_34_1","unstructured":"Australasian College for Emergency Medicine.Alcohol and Methamphetamine Harm in Emergency Departments: Findings from the 2019 Snapshot Survey.2020. [Cited 4 Nov 2021.] Available from URL:https:\/\/acem.org.au\/getmedia\/f7bec2c4\u20106573\u2010471f\u20108cf4\u2010f9a0bc466506\/Alcohol\u2010Snapshot\u2010Report_R6"}],"container-title":["Emergency Medicine Australasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1742-6723.14040","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/1742-6723.14040","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1742-6723.14040","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T20:52:43Z","timestamp":1692478363000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/1742-6723.14040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,20]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["10.1111\/1742-6723.14040"],"URL":"https:\/\/doi.org\/10.1111\/1742-6723.14040","archive":["Portico"],"relation":{},"ISSN":["1742-6731","1742-6723"],"issn-type":[{"value":"1742-6731","type":"print"},{"value":"1742-6723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,20]]},"assertion":[{"value":"2022-01-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-12","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}